|
209 Medicines
management needs more pharmacy input NHS hospitals should
make better use of pharmacists' clinical knowledge, the Healthcare Commission
indicated last week
PJ 2006;277:209
Full Text
209 Smart card
not necessarily needed to claim IT allowance Community pharmacy
contractors in England who have not been issued with smart cards may
still be able to claim allowances for the electronic prescription service,
NHS Primary Care Contracting has said
PJ 2006;277:209
Full Text
209 Airport security measures
affect carriage of liquid medicines Travellers may be concerned about
whether they will be allowed to carry their medicines on board flights after
hand luggage rescrictions were tightened in response to the recent threat to
UK security
PJ 2006;277:209
Full Text
210 Pharmacy
services need more effective promotion Public perceptions of pharmacy need to be brought up to date to help patients make best use of the wide range of services pharmacies now offer. This was one of the key messages raised at the first evidence session of the All Party Pharmacy Group inquiry into the future of pharmacy, held in London last week
PJ 2006;277:210
Full Text
210 Court backs Irish
ban on foreign pharmacists An Irish government ban that prevents pharmacists
who qualify in the UK, or elsewhere abroad, from owning or running a new pharmacy
in the Irish Republic has been upheld by the European Court
PJ 2006;277:210
Full Text
210 Clinical trial cytokine
storm details published Details of the cytokine storm suffered by
participants taking part in a phase 1 trial of the investigative compound TGN1412
in March have been published online
PJ 2006;277:210
Full Text
210 Reinstate pharmacy
supplies of oxygen, PSNC demands Home oxygen supply through pharmacies
should be reinstated in the South West of England, the Pharmaceutical Services
Negotiating Committee has demanded
PJ 2006;277:210
Full Text
210 COPD national service
framework Two pharmacists — Karen O’Brien, of Central Manchester Primary Care Trust, and Anna Murphy, of University Hospitals of Leicester NHS Trust — have been appointed to a 19-strong team of advisers who are to develop a national service framework for chronic obstructive pulmonary disease
PJ 2006;277:210
Full Text
211 Review
casts doubt on some new pharmacy roles Simply adding specialists, such as pharmacists, to traditional primary care teams of GPs and nurses is not enough to achieve the Government's aim of shifting some current hospital care to the community
PJ 2006;277:211
Full Text
211 Patient fraud cut
by more than 50 per cent Losses to the NHS due to patients making false claims for exemption from prescription, dental and optical charges have more than halved since steps to prevent evasion were introduced in 1998. The past eight years have seen annual losses cut from £170m to £76m
PJ 2006;277:211
Full Text
211 Scottish charge consultation
responses published online Calls for an overhaul of NHS prescription
charges have been made in Scotland. The views are expressed in responses to the
Scottish Executive's review of the charging system. However, what action the
Scottish Executive will take remains to be seen
PJ 2006;277:211
Full Text
211 Early forecasts show
a tiny surplus for NHS in England Early financial forecasts for the NHS in England published by the Department of Health last week show a surplus of £18m for 2006–07 after application of a £350m contingency created by strategic health authorities. The total budget for the year is more than £80bn
PJ 2006;277:211
Full Text
212 Fourth
HIV drug offers no benefit Patients starting treatment for HIV infection
do not benefit from the addition of a fourth drug to their antiretroviral regimen,
say US researchers
PJ 2006;277:212
Full Text
212 Simpler regimen for
maintenance HIV therapy A pilot study has shown that a simple regimen
of ritonavir-boosted atazanavir may be effective as maintenance therapy for some
HIV-infected patients
PJ 2006;277:212
Full Text
212 US AIDS panel updates
treatment recommendations The International AIDS Society's USA Panel
has issued updated recommendations for the treatment of HIV in settings where
there is relatively unrestricted access to drugs and monitoring tools
PJ 2006;277:212
Full Text
212 Welsh viral conjunctivitis
cluster under investigation Clustered
cases of viral conjunctivitis in the Rhondda Fach valley are being investigated
by the National Public Health Service for Wales (NPHS), which will examine how
common such outbreaks are
PJ 2006;277:212
Full Text
213 ACE
inhibitors may be of benefit in atherosclerosis Angiotensin-converting
enzyme (ACE) inhibitors should be considered for all patients with atherosclerosis,
including those with no history of heart failure or left ventricular systolic
dysfunction (LVSD), according to the authors of a recent study
PJ 2006;277:213
Full Text
213 Cardiac risk associated
with trastuzumab acceptable, data suggest Patients receiving trastuzumab
(Herceptin) therapy for HER-2 positive breast cancer are at risk of developing
cardiac toxicity, although for patients with advanced disease this risk may be
acceptable, according to US researchers
PJ 2006;277:213
Full Text
213 Risk of further stroke
reduced with high-dose statin use Statins can reduce the risk of further
strokes in people who have experienced a recent stroke or transient ischaemic
attack and who do not have a history of coronary heart disease, a recent study
suggests
PJ 2006;277:213
Full Text
214 Interventions
help customers curb harmful drinking Brief interventions by community
pharmacists may be able to reduce hazardous and harmful drinking, results of
a pilot study suggest
PJ 2006;277:214
Full Text
214 Tobacco dependence
is chronic disorder that needs ongoing therapy Tobacco dependence
might be better viewed as a chronic disorder requiring repeated episodes of treatment,
rather than a condition that can be cured with one course of treatment such as
nicotine replacement therapy (NRT), researchers suggest
PJ 2006;277:214
Full Text
214 Short course of mitoxantrone
shows promise as therapy for MS A treatment regimen involving a short
course of mitoxantrone and maintenance therapy with glatiramer acetate appears
to be effective in patients with active relapsing remitting multiple sclerosis
(MS), say UK researchers
PJ 2006;277:214
Full Text
R&D NEWS
215 Progress on pandemic
flu vaccine An investigational H5N1 pandemic influenza vaccine developed
by GlaxoSmithKline has yielded promising results in a recent clinical trial,
the company has revealed
PJ 2006;277:215
Full Text
215 Molecular basis of
drug resistance in lung cancer The molecular basis of resistance to
chemotherapy for small cell lung cancer has been identified by Cancer Research
UK researchers. The study may lead to the development of drugs to counteract
this type of resistance in this and other forms of cancer, they say
PJ 2006;277:215
Full Text
215 Antiviral protein
in lungs may hold key to future asthma treatments People with asthma produce less of an antiviral protein interferon-lambda (IFN-l) in response to rhinovirus infection than people without asthma, researchers have found
PJ 2006;277:215
Full Text
215 Nanoparticles designed
for use as overdose therapy US researchers have prepared particles (80–100nm) using reverse microemulsion polymerisation and tested them as potential drug scavengers for use after overdose
PJ 2006;277:215
Full Text
215 New HIV immunotherapy
vaccine envisaged Researchers are investigating various compounds
that immunomodulate dendritic cells in order to develop immunotherapy for HIV,
an abstract presented at the International AIDS Conference in Toronto this week
has revealed
PJ 2006;277:215
Full Text
|
The
Pharmaceutical Journal